Skip to main content
Acta Crystallographica Section E: Crystallographic Communications logoLink to Acta Crystallographica Section E: Crystallographic Communications
. 2018 Jul 20;74(Pt 8):1126–1129. doi: 10.1107/S2056989018010290

Crystal structure of N-allyl-4-methyl­benzene­sulfonamide

Zeel S Patel a, Amanda C Stevens a, Erin C Bookout a, Richard J Staples b, Shannon M Biros a, Felix N Ngassa a,*
PMCID: PMC6072992  PMID: 30116576

In the crystal structure of the title sulfonamide, inter­molecular N—H⋯O hydrogen bonds are present between sulfonamide groups, as well as offset π–π inter­actions.

Keywords: crystal structure, aryl sulfonamide, hydrogen bond, offset π–π inter­action

Abstract

The title compound, C10H13NO2S, was synthesized by a nucleophilic substitution reaction between allyl amine and p-toluene­sulfonyl chloride. The sulfonate S—O bond lengths are 1.4282 (17) and 1.4353 (17) Å, and the C—N—S—C torsion angle involving the sulfonamide moiety is −61.0 (2)°. In the crystal, centrosymmetric dimers of the title compound are present via inter­molecular N—H⋯O hydrogen bonds between sulfonamide groups. These dimers are linked into ribbons along the c-axis direction through offset π–π inter­actions.

Chemical context  

The sulfonamide moiety has been widely studied and its application in drug design has been reported (Qadir et al., 2015; Rehman et al., 2017; Gul et al., 2018). Sulfa drugs, which incorporate the sulfonamide moiety, have found applications as anti­bacterial, anti­cancer, anti­fungal, anti-inflammatory, and anti­viral agents (Alaoui et al., 2017).

The synthesis of sulfonamides generally relies on the use of sulfonyl chlorides as electrophilic partners that react with nucleophilic amines. According to the current state of knowledge in the field, the use of sulfonyl chlorides as electrophilic substrates in the synthesis of sulfonamides suffers from some drawbacks. One such drawback is the difficulty in handling and storage (Caddick et al., 2004). Other alternatives to sulfonyl chlorides have been reported (Parumala & Peddinti, 2016; Yang & Tian, 2017). Nucleophilic acyl substitution is the mechanism that describes the reaction between a carb­oxy­lic acid derivative such as acid chloride with an amine to form the corresponding amide. The mechanism of the reaction between sulfonyl chlorides and amines is analogous to nucleophilic acyl substitution, except that it occurs at the sulfonyl group and not the carbonyl group (Um et al., 2013).

Recently, we have been particularly inter­ested in the structural motif of sulfonamide compounds that are known to modulate 5-HT6 receptor activity and are used for the treatment of CNS diseases and disorders (Blass, 2016). We are also inter­ested in the therapeutic application of sulfonamide mol­ecules used for chondrogenic differentiation (Choi et al., 2016), and for the treatment of cancer (Gul et al., 2018). Fig. 1 shows the structure of Sulefonur, which has been reported as a potent anti­cancer sulfonamide drug candidate and is under anti­cancer clinical trials (Gul et al., 2018). As part of our ongoing effort to synthesize small sulfonamide mol­ecules that mimic the structural motifs of known sulfonamide drug candidates, we synthesized the title compound, C10H13NO2S, (I) and determined its crystal structure from single crystal X-ray diffraction data.graphic file with name e-74-01126-scheme1.jpg

Figure 1.

Figure 1

The structure of Sulefonur.

Structural commentary  

The mol­ecular structure of compound (I), which was solved in the triclinic space group P Inline graphic, is shown in Fig. 2. The S—O bond lengths of 1.4282 (17) and 1.4353 (17) Å and the O1—S1—O2 bond angle of 118.87 (11)° are typical for sulfonamide moieties. The S1—N1 bond length is 1.617 (2) Å, and the C1—N1—S1—C4 torsion angle is −61.0 (2)°.

Figure 2.

Figure 2

The mol­ecular structure of the title compound, showing the atom labeling. Displacement ellipsoids are drawn at the 50% probability level.

Supra­molecular features  

Mol­ecules of the title compound are linked to one another via hydrogen bonds and π–π inter­actions. Centrosymmetric dimers of compound (I) are formed through inter­molecular hydrogen bonds between the sulfonamide N—H group and an O atom of a neighbouring sulfonamide group (Fig. 3). The N1⋯O2i distance of 2.900 (3) Å suggests inter­actions of medium strength with a nearly linear N—H⋯O hydrogen bond of 174 (3)° (Table 1). These dimers are then linked through offset π–π inter­actions into ribbons that lie along the c axis (Figs. 3, 4). The inter­centroid distance CgCg ii is 3.8340 (17) Å, with a slippage of 1.320 Å and a plane-to-plane distance between phenyl rings of 3.600 Å [symmetry code (ii) = −x, −y, −z].

Figure 3.

Figure 3

A depiction of the inter­molecular hydrogen bonds and offset π–π inter­actions present in the crystal, viewed down the a axis, using a ball and stick model with standard CPK colors. [Symmetry codes: (i) −x, −y, −z + 1; (ii) −x, −y, −z.]

Table 1. Hydrogen-bond geometry (Å, °).

D—H⋯A D—H H⋯A DA D—H⋯A
N1—H1⋯O2i 0.83 (1) 2.07 (1) 2.900 (3) 174 (3)

Symmetry code: (i) Inline graphic.

Figure 4.

Figure 4

A view along the a axis of the title compound showing the supra­molecular ribbons assembled via N—H⋯O hydrogen bonds (blue, dashed lines) and π–π inter­actions (red, dotted lines).

Database survey  

The Cambridge Structural Database (CSD, Version 5.39, February 2018; Groom et al., 2016) contains 17 structures of p-tolyl­sulfonamides where there is a –CH2—C=C group bonded to the sulfonamide-N atom. The alkene group in these structures is a part of, for example, furan rings (DERTIE and DERTOK, Hashmi et al., 2006), an allene (XUDNEP, Lan & Hammond, 2002), and various acyclic systems (BUXYUQ, Kiyokawa et al., 2015; KIHMIY, Lee et al., 2007). While all of the structures listed here display inter­molecular hydrogen bonds between sulfonamide groups, none of them display π–π inter­actions between the p-tolyl­sulfonamide rings as seen in the title compound.

Synthesis and crystallization  

Allyl­amine (1.31 ml, 18 mmol) was added in 20 ml of degassed di­chloro­methane. This was followed by the addition of pyridine (1.42 ml, 18 mmol). The resulting solution was stirred under an atmosphere of N2, followed by the portion-wise addition of p-toluene­sulfonyl chloride (3.05 g, 16 mmol). The mixture was stirred at room temperature for 24 h. Reaction completion was verified by using TLC analysis. The mixture was acidified to pH 2–3 using concentrated HCl. After dilution with 20 ml of CH2Cl2, the organic phase was washed with H2O (3 × 20 ml) and the aqueous layer was back-extracted with CH2Cl2 (20 ml). The combined organic extracts were dried over anhydrous Na2SO4. After solvent evaporation, the residue was obtained as a yellow solid which was recrystallized in cold ethanol to afford pale-yellow crystals (56%; m.p. 332–333 K).

Refinement  

Crystal data, data collection and structure refinement details are summarized in Table 2. All hydrogen atoms bonded to carbon atoms were placed in calculated positions and refined as riding: Csp 3—H = 0.95–1.00 Å with U iso(H) = 1.2U eq(C) for methine and methyl­ene groups, and U iso(H) = 1.5U eq(C) for methyl groups. The hydrogen atom bonded to the nitro­gen atom (H1) was located using electron-density difference maps, and the N—H bond length was restrained to 0.84±0.01 Å using the DFIX command as executed in SHELXL (Sheldrick, 2015).

Table 2. Experimental details.

Crystal data
Chemical formula C10H13NO2S
M r 211.27
Crystal system, space group Triclinic, P Inline graphic
Temperature (K) 173
a, b, c (Å) 7.5538 (10), 8.2591 (11), 9.7145 (13)
α, β, γ (°) 85.9415 (16), 72.9167 (16), 67.6989 (15)
V3) 535.42 (12)
Z 2
Radiation type Mo Kα
μ (mm−1) 0.28
Crystal size (mm) 0.28 × 0.25 × 0.20
 
Data collection
Diffractometer Bruker APEXII CCD
Absorption correction Multi-scan (SADABS; Bruker, 2014)
T min, T max 0.672, 0.745
No. of measured, independent and observed [I > 2σ(I)] reflections 6472, 1963, 1564
R int 0.036
(sin θ/λ)max−1) 0.604
 
Refinement
R[F 2 > 2σ(F 2)], wR(F 2), S 0.053, 0.156, 1.09
No. of reflections 1963
No. of parameters 132
No. of restraints 1
H-atom treatment H atoms treated by a mixture of independent and constrained refinement
Δρmax, Δρmin (e Å−3) 0.60, −0.26

Computer programs: APEX2 and SAINT (Bruker, 2013), SHELXS (Sheldrick, 2008), SHELXL (Sheldrick, 2015), OLEX2 (Dolomanov et al., 2009; Bourhis et al., 2015) and CrystalMaker (Palmer, 2007).

Supplementary Material

Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989018010290/wm5455sup1.cif

e-74-01126-sup1.cif (124.7KB, cif)

Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989018010290/wm5455Isup2.hkl

e-74-01126-Isup2.hkl (108KB, hkl)

Supporting information file. DOI: 10.1107/S2056989018010290/wm5455Isup3.cml

CCDC reference: 1856234

Additional supporting information: crystallographic information; 3D view; checkCIF report

Acknowledgments

The authors thank Pfizer, Inc. for the donation of a Varian INOVA 400 FT NMR. The CCD-based X-ray diffractometers at Michigan State University were upgraded and/or replaced by departmental funds.

supplementary crystallographic information

Crystal data

C10H13NO2S Z = 2
Mr = 211.27 F(000) = 224
Triclinic, P1 Dx = 1.310 Mg m3
a = 7.5538 (10) Å Mo Kα radiation, λ = 0.71073 Å
b = 8.2591 (11) Å Cell parameters from 2805 reflections
c = 9.7145 (13) Å θ = 2.2–25.3°
α = 85.9415 (16)° µ = 0.28 mm1
β = 72.9167 (16)° T = 173 K
γ = 67.6989 (15)° Chunk, pale yellow
V = 535.42 (12) Å3 0.28 × 0.25 × 0.20 mm

Data collection

Bruker APEXII CCD diffractometer 1564 reflections with I > 2σ(I)
φ and ω scans Rint = 0.036
Absorption correction: multi-scan (SADABS; Bruker, 2014) θmax = 25.4°, θmin = 2.2°
Tmin = 0.672, Tmax = 0.745 h = −9→9
6472 measured reflections k = −9→9
1963 independent reflections l = −11→11

Refinement

Refinement on F2 Primary atom site location: structure-invariant direct methods
Least-squares matrix: full Hydrogen site location: mixed
R[F2 > 2σ(F2)] = 0.053 H atoms treated by a mixture of independent and constrained refinement
wR(F2) = 0.156 w = 1/[σ2(Fo2) + (0.0902P)2 + 0.112P] where P = (Fo2 + 2Fc2)/3
S = 1.09 (Δ/σ)max < 0.001
1963 reflections Δρmax = 0.60 e Å3
132 parameters Δρmin = −0.26 e Å3
1 restraint

Special details

Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)

x y z Uiso*/Ueq
S1 0.23035 (9) −0.06592 (8) 0.28093 (6) 0.0355 (3)
O1 0.4258 (2) −0.1649 (2) 0.19086 (19) 0.0423 (5)
O2 0.1100 (3) −0.1576 (2) 0.36436 (18) 0.0407 (5)
N1 0.2532 (3) 0.0508 (3) 0.3966 (2) 0.0352 (5)
H1 0.153 (3) 0.085 (4) 0.468 (2) 0.048 (8)*
C1 0.3608 (4) 0.1687 (4) 0.3441 (3) 0.0436 (7)
H1A 0.2923 0.2565 0.2830 0.052*
H1B 0.4984 0.1006 0.2847 0.052*
C2 0.3677 (4) 0.2590 (4) 0.4684 (3) 0.0483 (7)
H2 0.4323 0.1874 0.5339 0.058*
C3 0.2948 (6) 0.4239 (5) 0.4948 (4) 0.0705 (10)
H3A 0.2289 0.5005 0.4322 0.085*
H3B 0.3063 0.4703 0.5770 0.085*
C4 0.0966 (3) 0.0803 (3) 0.1729 (3) 0.0318 (6)
C5 −0.1007 (4) 0.1904 (3) 0.2347 (3) 0.0390 (6)
H5 −0.1655 0.1827 0.3334 0.047*
C6 −0.2011 (4) 0.3105 (4) 0.1516 (3) 0.0424 (7)
H6 −0.3363 0.3849 0.1937 0.051*
C7 −0.1092 (4) 0.3257 (3) 0.0072 (3) 0.0397 (6)
C8 0.0869 (4) 0.2125 (4) −0.0528 (3) 0.0423 (7)
H8 0.1509 0.2187 −0.1520 0.051*
C9 0.1909 (4) 0.0909 (4) 0.0291 (3) 0.0380 (6)
H9 0.3258 0.0156 −0.0130 0.046*
C10 −0.2180 (5) 0.4608 (4) −0.0817 (3) 0.0506 (7)
H10A −0.1212 0.4891 −0.1614 0.076*
H10B −0.3076 0.5669 −0.0212 0.076*
H10C −0.2964 0.4147 −0.1205 0.076*

Atomic displacement parameters (Å2)

U11 U22 U33 U12 U13 U23
S1 0.0316 (4) 0.0323 (4) 0.0372 (4) −0.0107 (3) −0.0031 (3) −0.0010 (3)
O1 0.0323 (10) 0.0378 (10) 0.0444 (10) −0.0067 (8) −0.0007 (8) −0.0047 (8)
O2 0.0425 (10) 0.0322 (10) 0.0428 (10) −0.0158 (9) −0.0034 (8) 0.0010 (8)
N1 0.0325 (11) 0.0363 (12) 0.0333 (11) −0.0124 (10) −0.0049 (9) 0.0010 (9)
C1 0.0464 (16) 0.0444 (16) 0.0430 (15) −0.0237 (13) −0.0087 (12) 0.0036 (12)
C2 0.0484 (17) 0.0476 (18) 0.0550 (17) −0.0218 (14) −0.0196 (14) 0.0063 (14)
C3 0.084 (3) 0.056 (2) 0.073 (2) −0.0282 (19) −0.020 (2) −0.0084 (18)
C4 0.0280 (12) 0.0331 (13) 0.0346 (13) −0.0140 (11) −0.0058 (10) −0.0009 (10)
C5 0.0337 (14) 0.0439 (16) 0.0344 (13) −0.0135 (12) −0.0032 (11) −0.0019 (12)
C6 0.0334 (14) 0.0474 (17) 0.0421 (15) −0.0113 (12) −0.0086 (12) −0.0027 (13)
C7 0.0431 (15) 0.0423 (16) 0.0433 (15) −0.0228 (13) −0.0173 (12) 0.0013 (12)
C8 0.0415 (15) 0.0546 (17) 0.0312 (13) −0.0227 (14) −0.0045 (11) 0.0008 (12)
C9 0.0339 (14) 0.0442 (15) 0.0337 (13) −0.0169 (12) −0.0022 (11) −0.0038 (11)
C10 0.0553 (18) 0.0505 (18) 0.0528 (17) −0.0216 (15) −0.0242 (14) 0.0076 (14)

Geometric parameters (Å, º)

S1—O1 1.4282 (17) C4—C9 1.383 (3)
S1—O2 1.4353 (17) C5—H5 0.9500
S1—N1 1.617 (2) C5—C6 1.373 (4)
S1—C4 1.760 (3) C6—H6 0.9500
N1—H1 0.831 (10) C6—C7 1.390 (4)
N1—C1 1.468 (3) C7—C8 1.388 (3)
C1—H1A 0.9900 C7—C10 1.501 (4)
C1—H1B 0.9900 C8—H8 0.9500
C1—C2 1.487 (4) C8—C9 1.383 (4)
C2—H2 0.9500 C9—H9 0.9500
C2—C3 1.273 (4) C10—H10A 0.9800
C3—H3A 0.9500 C10—H10B 0.9800
C3—H3B 0.9500 C10—H10C 0.9800
C4—C5 1.390 (3)
O1—S1—O2 118.87 (11) C9—C4—C5 120.4 (2)
O1—S1—N1 107.94 (11) C4—C5—H5 120.3
O1—S1—C4 108.08 (11) C6—C5—C4 119.3 (2)
O2—S1—N1 105.56 (11) C6—C5—H5 120.3
O2—S1—C4 108.64 (11) C5—C6—H6 119.3
N1—S1—C4 107.21 (11) C5—C6—C7 121.5 (2)
S1—N1—H1 112 (2) C7—C6—H6 119.3
C1—N1—S1 119.02 (17) C6—C7—C10 121.1 (3)
C1—N1—H1 118 (2) C8—C7—C6 118.2 (2)
N1—C1—H1A 109.7 C8—C7—C10 120.7 (2)
N1—C1—H1B 109.7 C7—C8—H8 119.4
N1—C1—C2 109.8 (2) C9—C8—C7 121.2 (2)
H1A—C1—H1B 108.2 C9—C8—H8 119.4
C2—C1—H1A 109.7 C4—C9—C8 119.3 (2)
C2—C1—H1B 109.7 C4—C9—H9 120.3
C1—C2—H2 117.1 C8—C9—H9 120.3
C3—C2—C1 125.7 (3) C7—C10—H10A 109.5
C3—C2—H2 117.1 C7—C10—H10B 109.5
C2—C3—H3A 120.0 C7—C10—H10C 109.5
C2—C3—H3B 120.0 H10A—C10—H10B 109.5
H3A—C3—H3B 120.0 H10A—C10—H10C 109.5
C5—C4—S1 119.60 (19) H10B—C10—H10C 109.5
C9—C4—S1 119.9 (2)

Hydrogen-bond geometry (Å, º)

D—H···A D—H H···A D···A D—H···A
N1—H1···O2i 0.83 (1) 2.07 (1) 2.900 (3) 174 (3)

Symmetry code: (i) −x, −y, −z+1.

Funding Statement

This work was funded by National Science Foundation grants CCLI CHE-0087655 and MRI CHE-1725699. GVSU Chemistry Department’s Weldon Fund grant .

References

  1. Alaoui, S., Dufies, M., Driowya, M., Demange, L., Bougrin, K., Robert, G., Auberger, P., Pagès, G. & Benhida, R. (2017). Bioorg. Med. Chem. Lett. 27, 1989–1992. [DOI] [PubMed]
  2. Blass, B. (2016). ACS Med. Chem. Lett. 7, 12–14. [DOI] [PMC free article] [PubMed]
  3. Bourhis, L. J., Dolomanov, O. V., Gildea, R. J., Howard, J. A. K. & Puschmann, H. (2015). Acta Cryst. A71, 59–75. [DOI] [PMC free article] [PubMed]
  4. Bruker (2013). APEX2 and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.
  5. Bruker (2014). SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
  6. Caddick, S., Wilden, J. D. & Judd, D. B. (2004). J. Am. Chem. Soc. 126, 1024–1025. [DOI] [PubMed]
  7. Choi, E., Lee, J., Lee, S., Song, B. W., Seo, H. H., Cha, M. J., Lim, S., Lee, C., Song, S. W., Han, G. & Hwang, K. C. (2016). Bioorg. Med. Chem. Lett. 26, 5098–5102. [DOI] [PubMed]
  8. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K. & Puschmann, H. (2009). J. Appl. Cryst. 42, 339–341.
  9. Groom, C. R., Bruno, I. J., Lightfoot, M. P. & Ward, S. C. (2016). Acta Cryst. B72, 171–179. [DOI] [PMC free article] [PubMed]
  10. Gul, H. I., Yamali, C., Sakagami, H., Angeli, A., Leitans, J., Kazaks, A., Tars, K., Ozgun, D. O. & Supuran, C. T. (2018). Bioorg. Chem. 77, 411–419. [DOI] [PubMed]
  11. Hashmi, A. S. K., Weyrauch, J. P., Kurpejović, E., Frost, T. M., Miehlich, B., Frey, W. & Bats, J. W. (2006). Chem. Eur. J. 12, 5806–5814. [DOI] [PubMed]
  12. Kiyokawa, K., Kojima, T., Hishikawa, Y. & Minakata, S. (2015). Chem. Eur. J. 21, 15548–15552. [DOI] [PubMed]
  13. Lan, Y. & Hammond, G. B. (2002). Org. Lett. 4, 2437–2439. [DOI] [PubMed]
  14. Lee, Y. T., Choi, S. Y. & Chung, Y. K. (2007). Tetrahedron Lett. 48, 5673–5677.
  15. Palmer, D. (2007). CrystalMaker. CrystalMaker, Bicester, England.
  16. Parumala, S. K. R. & Peddinti, R. K. (2016). Tetrahedron Lett. 57, 1232–1235.
  17. Qadir, M. A., Ahmed, M. & Khaleeq, A. (2015). Lat. Am. J. Pharm. 34, 719–724.
  18. Rehman, H., Qadir, M. A., Shad, H. A. & Khan, Z. I. (2017). Med. Chem. (Los Angeles) 7, 252–256.
  19. Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. [DOI] [PubMed]
  20. Sheldrick, G. M. (2015). Acta Cryst. C71, 3–8.
  21. Um, I. H., Kang, J. S., Shin, Y. H. & Buncel, E. (2013). J. Org. Chem. 78, 490–497. [DOI] [PubMed]
  22. Yang, F.-L. & Tian, S.-K. (2017). Tetrahedron Lett. 58, 487–504.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989018010290/wm5455sup1.cif

e-74-01126-sup1.cif (124.7KB, cif)

Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989018010290/wm5455Isup2.hkl

e-74-01126-Isup2.hkl (108KB, hkl)

Supporting information file. DOI: 10.1107/S2056989018010290/wm5455Isup3.cml

CCDC reference: 1856234

Additional supporting information: crystallographic information; 3D view; checkCIF report


Articles from Acta Crystallographica Section E: Crystallographic Communications are provided here courtesy of International Union of Crystallography

RESOURCES